Novartis Aktie
102,90
EUR
+3,38
EUR
+3,40
%
97,36
CHF
+3,56
CHF
+3,80
%
Werbung
Novartis Aktie Analyse
| 26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 11.05.16 | Novartis buy | Jefferies & Company Inc. | |
| 26.04.16 | Novartis Outperform | Bernstein Research | |
| 26.04.16 | Novartis buy | HSBC | |
| 25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 21.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.16 | Novartis buy | HSBC | |
| 22.02.16 | Novartis buy | Jefferies & Company Inc. | |
| 19.02.16 | Novartis kaufen | JP Morgan Chase & Co. | |
| 01.02.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.16 | Novartis buy | HSBC | |
| 28.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.01.16 | Novartis buy | UBS AG | |
| 19.01.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.01.16 | Novartis buy | Jefferies & Company Inc. | |
| 11.01.16 | Novartis kaufen | UBS AG | |
| 06.01.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 07.12.15 | Novartis buy | Jefferies & Company Inc. | |
| 02.12.15 | Novartis buy | Citigroup Corp. | |
| 05.11.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 05.11.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.10.15 | Novartis Outperform | Bernstein Research | |
| 28.10.15 | Novartis buy | Kepler Cheuvreux | |
| 28.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.10.15 | Novartis Outperform | BNP PARIBAS | |
| 21.10.15 | Novartis Outperform | Bernstein Research | |
| 16.10.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 12.10.15 | Novartis buy | Jefferies & Company Inc. | |
| 25.09.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.09.15 | Novartis buy | Citigroup Corp. | |
| 16.09.15 | Novartis buy | HSBC | |
| 10.09.15 | Novartis buy | Jefferies & Company Inc. | |
| 01.09.15 | Novartis buy | UBS AG | |
| 24.08.15 | Novartis buy | UBS AG | |
| 07.08.15 | Novartis buy | Jefferies & Company Inc. | |
| 27.07.15 | Novartis buy | UBS AG | |
| 24.07.15 | Novartis buy | Kepler Cheuvreux | |
| 23.07.15 | Novartis Outperform | BNP PARIBAS | |
| 22.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.07.15 | Novartis buy | Citigroup Corp. | |
| 13.07.15 | Novartis buy | Jefferies & Company Inc. | |
| 10.07.15 | Novartis buy | UBS AG | |
| 09.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
Werbung
Werbung